Oramed Pharmaceuticals In... (ORMP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.35
-0.01 (-0.42%)
At close: Jan 15, 2025, 3:59 PM
2.34
-0.21%
After-hours Jan 15, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 |
Revenue | 1.34M | 2.70M | 2.70M | 2.71M | 2.70M | 2.45M | 2.46M | 641.00K | n/a | n/a | n/a | 184.25K | 197.41K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 90.00K | 90.00K | 86.00K | 187.00K | 490.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.34M | 2.70M | 2.70M | 2.62M | 2.61M | 2.36M | 2.27M | 151.00K | n/a | n/a | n/a | 184.25K | 197.41K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -15.77M | -40.60M | -24.22M | -11.76M | -14.63M | -13.53M | -10.77M | -10.01M | -7.38M | -5.91M | -4.30M | 2.88M | -2.44M | -2.97M | -2.78M | -2.68M | -3.13M | -412.88K | -44.81K | -720.00K | -50.00K |
Interest Income | 8.03M | 3.57M | 347.00K | 690.00K | 1.06M | 903.00K | 785.00K | 474.00K | 168.00K | 225.00K | 18.73K | 13.13K | 33.23K | 24.69K | 38.60K | -83.19K | -11.00K | 1.99K | n/a | n/a | n/a |
Pretax Income | 5.09M | -37.66M | -22.99M | -11.51M | -14.05M | -12.73M | -10.08M | -9.63M | -7.23M | -5.69M | -4.44M | -3.25M | -1.59M | -2.96M | -2.76M | 2.61M | -3.24M | -414.58K | -45.78K | -720.00K | -50.00K |
Net Income | 5.53M | -37.76M | -22.24M | -11.51M | -14.36M | -12.73M | -10.48M | -10.96M | -7.23M | -5.70M | -4.23M | -3.34M | -1.56M | -2.98M | -2.76M | -2.77M | -3.24M | -414.58K | -45.78K | -720.00K | -50.00K |
Selling & General & Admin | 8.14M | 15.66M | 5.94M | 4.23M | 3.72M | 4.08M | 2.76M | 2.45M | 2.60M | 2.63M | 2.03M | 1.20M | 1.28M | 1.51M | 1.26M | 1.50M | 918.00K | 215.13K | 44.81K | 280.00K | 50.00K |
Research & Development | 8.97M | 27.64M | 20.99M | 10.23M | 13.52M | 11.98M | 10.28M | 7.71M | 4.78M | 3.28M | 2.27M | 1.68M | 1.16M | 1.46M | 1.52M | 1.18M | 2.21M | 197.75K | n/a | n/a | 10.00K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 440.00K | -10.00K |
Operating Expenses | 17.11M | 43.30M | 26.93M | 14.47M | 17.24M | 16.06M | 13.04M | 10.16M | 7.38M | 5.91M | 4.30M | 2.88M | 2.44M | 2.97M | 2.78M | 2.68M | 3.13M | 412.88K | 44.81K | 720.00K | 50.00K |
Interest Expense | 3.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.00K | 313.45K | 199.12K | 18.78K | 14.54K | 17.55K | 10.28K | -3.24M | 3.68K | -44.81K | n/a | n/a |
Selling & Marketing Expenses | -287.00K | 1.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.11M | 43.30M | 26.93M | 14.47M | 17.33M | 15.98M | 13.23M | 10.65M | 7.38M | 5.91M | 4.30M | 2.88M | 2.44M | 2.97M | 2.78M | 2.68M | 3.13M | 412.88K | 44.81K | 720.00K | 50.00K |
Income Tax | n/a | 100.00K | -2.88M | 192.00K | 300.00K | -800.00K | 400.00K | 1.33M | -1K | 4.00K | -205.06K | 90.22K | -23.98K | 14.97K | -2.60K | 162.16K | 3.24M | 414.58K | 45.78K | n/a | n/a |
Shares Outstanding (Basic) | 40.32M | 39.00M | 28.47M | 20.53M | 17.45M | 14.88M | 13.31M | 12.62M | 10.82M | 9.24M | 7.21M | 5.88M | 5.42M | 4.78M | 4.72M | 4.05M | 3.52M | 2.78M | 1.54M | 2.54M | 2.90M |
Shares Outstanding (Diluted) | 40.57M | 39.00M | 28.47M | 20.53M | 17.45M | 14.88M | 13.31M | 12.62M | 10.82M | 9.24M | 7.21M | 5.88M | 5.42M | 4.78M | 4.72M | 4.05M | 3.52M | 2.78M | 1.54M | 2.54M | 2.90M |
EPS (Basic) | 0.14 | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 | -0.59 | -0.57 | -0.29 | -0.62 | -0.58 | -0.68 | -0.92 | -0.15 | -0.03 | -0.28 | -0.02 |
EPS (Diluted) | 0.14 | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 | -0.59 | -0.57 | -0.29 | -0.62 | -0.58 | -0.68 | -0.92 | -0.15 | -0.03 | -0.28 | -0.02 |
EBITDA | -15.57M | -36.98M | -25.04M | -11.31M | -14.17M | -13.49M | -10.76M | -9.99M | -7.38M | -5.67M | -4.13M | -2.86M | -2.37M | -2.92M | -2.72M | -2.66M | -3.02M | -412.88K | -44.81K | -720.00K | -50.00K |
Depreciation & Amortization | 196.00K | 3.62M | 77.00K | 7.00K | 8.00K | 6.00K | 5.00K | 4.00K | 4.00K | 6.00K | 5.38K | 14.74K | 28.30K | 31.86K | 30.49K | 15.45K | 108.00K | -1.69K | -973 | n/a | n/a |